✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

RemeGen Co Ltd

Common Name
RemeGen
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
3,048
Ticker
688331
Exchange
Shanghai Stock Exchange
Description
RemeGen Co., Ltd. is a biotechnology company focusing on the research, development, and commercialization of novel biologics for the treatment of cancer, autoimmune disorders, and other serious diseas...

RemeGen's Revenues Data

Explore RemeGen's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
463,024,430a
234,328,379a
151,418,324b
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind RemeGen’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. RemeGen's Annual Report 2025
b. RemeGen's Annual Report 2024